[4] Both of these are, mechanistically, more about limiting damage (neuroprotection and vascular/edema effects) than about regenerating lost neurons a distinction that matters for the central comparison, because it suggests BPC-157s CNS story is weighted toward protection and vascular support rather than the progenitor-driven remodeling seen with thymosin beta-4
The intranasal formulations are not approved to treat acute B12 deficiency
BPC-157 costs approximately $250/month for daily self-injection, with a total protocol cost of $250-750 over 1-3 months
Blood 127:139148 Bruce LJ, Anstee DJ (2016) Unconventional cell death in erythroid cells
Many protocols suggest the following structure: Monday through Friday : Daily TB-500 injections Saturday and Sunday : Rest days Duration : 4-12 week cycles followed by rest periods Some treatment plans specify injections every 3.5 days rather than daily administration .[1] This less frequent approach can be particularly beneficial for those who prefer fewer injections while maintaining therapeutic benefits
These entities are essentially comprised of solid neoplasms, haematological malignancies and liver and kidney diseases